Literature DB >> 14649309

Patients with essential hypertension present higher levels of sE-selectin and sVCAM-1 than normotensive volunteers.

Iván Palomo1, Patricio Marín, Marcelo Alarcón, Gilda Gubelin, Ximena Viñambre, Eduardo Mora, Gloria Icaza.   

Abstract

In essential hypertension (EH) patients, blood pressure can modify serum concentrations of some soluble forms of cell adhesion molecules (CAM), e.g., soluble E-selectin (sE-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1). The objective of this study was to compare the serum levels of these CAMs in compensated (CH) and non-compensated (NCH) EH patients. Our findings show that sE-selectin and sVCAM-1 levels are higher in EH patients than normotensive subjects (sVCAM-1: 796+/-52 vs. 605+/-24 ng/mL, p<0.0001, and sE-selectin: 71+/-21 vs. 48+/-14 ng/mL, p<0.0001). Serum concentrations of both CAMs was higher in NCH patients than CH patients. High arterial blood pressure (ABP) may therefore increase the production of cell adhesion molecules, probably through endothelial activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14649309     DOI: 10.1081/ceh-120025335

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  7 in total

Review 1.  Interactions Between the Immune and the Renin-Angiotensin Systems in Hypertension.

Authors:  Nathan P Rudemiller; Steven D Crowley
Journal:  Hypertension       Date:  2016-06-27       Impact factor: 10.190

Review 2.  Salt, Hypertension, and Immunity.

Authors:  A Justin Rucker; Nathan P Rudemiller; Steven D Crowley
Journal:  Annu Rev Physiol       Date:  2017-11-16       Impact factor: 19.318

Review 3.  The role of macrophages in hypertension and its complications.

Authors:  A Justin Rucker; Steven D Crowley
Journal:  Pflugers Arch       Date:  2017-03-01       Impact factor: 3.657

4.  Circulating levels of cell adhesion molecules in hypertension.

Authors:  Kavita K Shalia; Manoj R Mashru; Jagdish B Vasvani; Rajashree A Mokal; Shilpa M Mithbawkar; Priti K Thakur
Journal:  Indian J Clin Biochem       Date:  2009-12-30

5.  Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance).

Authors:  Julia C F Quintanilha; Yingmiao Liu; Amy S Etheridge; Akram Yazdani; Hedy L Kindler; William Kevin Kelly; Andrew B Nixon; Federico Innocenti
Journal:  Angiogenesis       Date:  2021-05-24       Impact factor: 9.596

Review 6.  Pivotal roles of monocytes/macrophages in stroke.

Authors:  Tsuyoshi Chiba; Keizo Umegaki
Journal:  Mediators Inflamm       Date:  2013-01-27       Impact factor: 4.711

7.  Comparison of biomarkers of endothelial dysfunction and microvascular endothelial function in patients with primary aldosteronism and essential hypertension.

Authors:  Miaomiao Sang; Yu Fu; Chenmin Wei; Jing Yang; Xueting Qiu; Jingqing Ma; Chao Qin; Feiyan Wu; Xueling Zhou; Tao Yang; Min Sun
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021 Jan-Dec       Impact factor: 1.636

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.